These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7794630

  • 1. A cross-sectional study of growth, puberty and endocrine function in patients with thalassaemia major in Hong Kong.
    Kwan EY, Lee AC, Li AM, Tam SC, Chan CF, Lau YL, Low LC.
    J Paediatr Child Health; 1995 Apr; 31(2):83-7. PubMed ID: 7794630
    [Abstract] [Full Text] [Related]

  • 2. Growth and management of short stature in thalassaemia major.
    Theodoridis C, Ladis V, Papatheodorou A, Berdousi H, Palamidou F, Evagelopoulou C, Athanassaki K, Konstantoura O, Kattamis C.
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 3():835-44. PubMed ID: 10091154
    [Abstract] [Full Text] [Related]

  • 3. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study.
    Soliman AT, elZalabany M, Amer M, Ansari BM.
    J Trop Pediatr; 1999 Feb; 45(1):23-30. PubMed ID: 10191589
    [Abstract] [Full Text] [Related]

  • 4. Growth, puberty and endocrine function in beta-thalassaemia major.
    Low LC.
    J Pediatr Endocrinol Metab; 1997 Feb; 10(2):175-84. PubMed ID: 9364350
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency.
    Low LC, Kwan EY, Lim YJ, Lee AC, Tam CF, Lam KS.
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):359-63. PubMed ID: 7750189
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Growth and sexual maturation in children with thalassemia major.
    Yesilipek MA, Bircan I, Oygür N, Ertug H, Yegin O, Güven AG.
    Haematologica; 1993 Apr; 78(1):30-3. PubMed ID: 8491419
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L, Gurrado R, Zecchino C, Manolo F, De Sanctis V, Cisternino M, Caruso-Nicoletti M, Galati M.
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 3():845-9. PubMed ID: 10091155
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
    Moayeri H, Oloomi Z.
    Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
    [Abstract] [Full Text] [Related]

  • 11. Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases.
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):581-6. PubMed ID: 7634497
    [Abstract] [Full Text] [Related]

  • 12. Failure of puberty in Egyptian beta thalassemic patients: experience in north east region - Dakahlia province.
    Abdelrazik N, Ghanem H.
    Hematology; 2007 Oct; 12(5):449-56. PubMed ID: 17852439
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
    De Sanctis V, Eleftheriou A, Malaventura C, Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia.
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
    [Abstract] [Full Text] [Related]

  • 14. Endocrine complications in patients with Thalassaemia Major.
    Toumba M, Sergis A, Kanaris C, Skordis N.
    Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
    [Abstract] [Full Text] [Related]

  • 15. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia.
    De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC, Italian Working Group on Endocrine Complications in Non-Endocrine Diseases.
    J Pediatr Endocrinol Metab; 2006 Apr; 19(4):471-80. PubMed ID: 16759032
    [Abstract] [Full Text] [Related]

  • 16. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
    Casale M, Citarella S, Filosa A, De Michele E, Palmieri F, Ragozzino A, Amendola G, Pugliese U, Tartaglione I, Della Rocca F, Cinque P, Nobili B, Perrotta S.
    Am J Hematol; 2014 Dec; 89(12):1102-6. PubMed ID: 25197009
    [Abstract] [Full Text] [Related]

  • 17. Growth of children with beta-thalassemia major.
    Low LC.
    Indian J Pediatr; 2005 Feb; 72(2):159-64. PubMed ID: 15758540
    [Abstract] [Full Text] [Related]

  • 18. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
    de Waal WJ, Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Drop SL.
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.